September 18, 2025 The Critical Path Institute Podcast: Connecting the Dots in Pediatrics C-Path is excited to share the latest episode of our Connecting the Dots podcast. In this episode, C-Path CEO Klaus...
September 12, 2025 2025 C-Path Global Impact Conference in Washington D.C. a Huge Success Building on the momentum of CGIC 2024, this year’s event brought together leaders and innovators from across the life sciences..
September 11, 2025 C-Path Concludes 2025 Global Impact Conference with Progress Across Rare Diseases, Neurology and Pediatrics Global regulators, industry leaders, scientists, and patient advocates set near-term commitments on early interception...
September 10, 2025 C-Path’s Global Impact Conference | Every Stage, Every Step: Transforming Lives Through Optimized Drug Development | Day 2 Recap Day 2 of the C-Path Global Impact Conference built on the momentum of opening day...
September 9, 2025 C-Path’s Global Impact Conference | Every Stage, Every Step: Transforming Lives Through Optimized Drug Development | Day 1 Recap Day 1 of Critical Path Institute's Global Impact Conference, #CGIC2025, opened with powerful conversations on accelerating...
September 8, 2025 C-Path Welcomes Rare Disease Advocacy Leader Ronald J. Bartek to Board of Directors C-Path today announced the election of Ronald J. Bartek to its Board of Directors...
September 8, 2025 Shaping the Future of AATD: Patient Perspectives to Drive the Next Decade of Innovation in Alpha-1 Antitrypsin Deficiency On September 8, C-Path and the Alpha-1 Foundation are co-hosting a virtual workshop, Shaping the Future of AATD: Patient...
September 7, 2025 World Duchenne Awareness Day: Celebrating 10 Years of D-RSC’s Commitment to Serve the Duchenne Community Today is the World Duchenne Awareness Day (WDAD), an annual event that raises global awareness and understanding of Duchenne...
September 4, 2025 C-Path’s Translational Therapeutics Accelerator Marks Record Year with Seven BRIDGe Awards Advancing Potential Therapies Across Cancer, Infectious Disease, Neurology and Immunology Program launched in 2022 has grown into a global pipeline partner for academic teams, awarding approximately $2.48 million...
September 4, 2025 From Data to Hope: C-Path’s Polycystic Kidney Disease Outcomes Consortium and the Power of Data Sharing Every year on September 4, families, patients, advocates, and researchers come together to recognize Polycystic Kidney Disease...
